WaleedSShalabyMD

PubMed

• Prognostic Value of Fibroblast Growth Factor Receptor Genetic Alterations in Metastatic Urothelial Carcinoma.
  Fleming, S., Gifkins, D., Resnick, H., Rosenberg, P., Gaj, C., Maio, V., Crawford, A., Lu-Yao, G., Shalaby, W., Gao, J., Siefker-Radtke, A.> ;Clinical Genitourinary Cancer. 2024 Feb 15
• 6 citations
  Cardiac safety of trabectedin monotherapy or in combination with pegylated liposomal doxorubicin in patients with sarcomas and ovarian cancer.
  Robin L. Jones, Thomas J. Herzog, Shreyaskumar Patel, Margaret von Mehren, Scott M. Schuetze, Brian A. Van Tine, Robert L. Coleman, Roland Elmar Knoblauch, Spyros Tria...> ;Cancer Medicine. 2021 May 7
• 2 citations
  Data on Prior Pegylated Liposomal Doxorubicin (PLD) Treatment in Recurrent Ovarian Cancer: Post-hoc Data Analysis From the Phase 3 Randomized, Open-label Study Compari...
  Bradley J. Monk, Thomas J. Herzog, George Wang, Spyros Triantos, Scott Maul, Roland Elmar Knoblauch, Tracy McGowan, Waleed Shalaby, Robert L. Coleman> ;Data in Brief. 2020 Mar 20
• 23 citations
  A phase 3 randomized, open-label, multicenter trial for safety and efficacy of combined trabectedin and pegylated liposomal doxorubicin therapy for recurrent ovarian c...
  Bradley J. Monk, Thomas J. Herzog, George Wang, Spyros Triantos, Scott Maul, Roland Elmar Knoblauch, Tracy McGowan, Waleed Shalaby, Robert L. Coleman> ;Gynecologic Oncology. 2020 Mar 1
• 8 citations
  Safety and efficacy of trabectedin when administered in the inpatient versus outpatient setting: Clinical considerations for outpatient administration of trabectedin.
  Robin L. Jones, Robert G. Maki, Shreyaskumar Patel, George Wang, Tracy McGowan, Waleed Shalaby, Roland Elmar Knoblauch, Margaret von Mehren, George D. Demetri> ;Cancer. 2019 Dec 15
• 6 citations
  Development and usability of a new subcutaneous auto-injector device to administer hydroxyprogesterone caproate to reduce the risk of recurrent preterm birth.
  Michael N Travanty, Bryon Calawa, Waleed Sw Shalaby, Michael J. Jozwiakowski, Kyle B Haraldsen> ;Medical Devices. 2018 Jul 24
• 4 citations
  Injectable in situ forming controlled release implant composed of a poly-ether-ester-carbonate and applications in the field of chemotherapy.
  Jason Olbrich, Patilee L. Tate, Joel Thomas Corbett, James M. Lindsey, Sheila Nagatomi, Waleed S. W. Shalaby, Shalaby W. Shalaby> ;Journal of Biomedical Materials Research. Part A. 2012 Sep 1
• 9 citations
  Absorbable microparticulate cation exchanger for immunotherapeutic delivery.
  Waleed S.W. Shalaby, Heidi Yeh, Edward Y. Woo, Joel Thomas Corbett, Heidi J. Gray, Carl H. June, Shalaby W. Shalaby> ;Journal of Biomedical Materials Research. Part B, Applied Biomaterials. 2004 May 15
• 1 citations
  Development of novel substrates for tumor immunotherapy.
  Waleed S. W. Shalaby, Heidi Yeh, Edward Y. Woo, Samantha K. Hendren, Joel Thomas Corbett, Heidi J. Gray, Carl H. June, Shalaby W. Shalaby> ;Journal of Controlled Release. 2003 Aug 28
• 75 citations
  A Cell-Based Artificial Antigen-Presenting Cell Coated with Anti-CD3 and CD28 Antibodies Enables Rapid Expansion and Long-Term Growth of CD4 T Lymphocytes
  Anna K. Thomas, Marcela V. Maus, Waleed S.W. Shalaby, Carl H. June, James L. Riley> ;Clinical Immunology. 2002 Dec 1
• Join now to see all